For this purpose, we assessed neurogenesis rate by immunolabeling DCX, a marker of NPCs, 1 week after stroke, and found that PDGF-D did not affect DCX+ cell density in the SVZ/LV (VEH:11739 ± 4435, P250:20556 ± 10,095). This evidence concerns the gene DCX and stroke disorder.